UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000030782
Receipt No. R000035143
Scientific Title Phase II study for efficacy and safety of pembrolizumab for the cytotoxic chemotherapy unfit previously untreated or treated PD-L1 positive advanced non-small cell lung cancer
Date of disclosure of the study information 2018/01/12
Last modified on 2019/03/22 12:13:29

No. Disposal Last modified on Item of update
1 Insert 2018/01/12 11:14:26
2 Update 2019/03/22 12:09:02 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
3 Update 2019/03/22 12:10:43 Date of IRB
Last follow-up date
4 Update 2019/03/22 12:11:41 Public title
Public title
Scientific Title
5 Update 2019/03/22 12:12:22 Narrative objectives1
Narrative objectives1
6 Update 2019/03/22 12:13:29 Interventions/Control_1
Interventions/Control_1
Key inclusion criteria
Key inclusion criteria


Contact us.